Navigation Links
First Gene Therapy Human Trial For Muscular Dystrophy In Progress

The first clinical trial of gene therapy is underway for muscular dystrophy in the United States. //

The clinical trial for Duchenne muscular dystrophy (DMD) tests the safety and effectiveness of a therapy that was developed over two decades by scientists at the University of North Carolina at Chapel Hill's School of Medicine and the University of Pittsburgh.

The trial was launched March 28, at Columbus Children's Hospital in Ohio, an affiliate of Ohio State University's School of Medicine. In the trial, six boys with DMD will receive replacement genes for an essential muscle protein.

Each of the boys will receive replacement genes via injection into a bicep of one arm and a placebo in the other arm. Neither the investigators nor the participants will know which muscle got the genes. After several weeks, an analysis of the injected muscle tissue's microscopic appearance, as well as extensive testing of the health and strength of the trial participants, will reveal whether gene therapy for DMD is likely to be safe and whether it's likely to result in persistent production of the essential protein in muscle cells.

Muscular dystrophies are genetic disorders characterized by progressive muscle wasting and weakness that begin with microscopic changes in the muscle. As muscles degenerate over time, the person's muscle strength declines.

Duchenne muscular dystrophy is a genetic disease that begins in early childhood, causes progressive loss of muscle strength and bulk, and usually leads to death in the 20s from respiratory or cardiac muscle failure. DMD occurs when a gene on the X chromosome fails to make the essential muscle protein dystrophin. One of nine types of muscular dystrophy, DMD primarily affects boys.

Currently, the best medical therapy can only slow the progressive muscle weakness of DMD.

The gene for dystrophin is one of the largest genes in the human body, and miniaturi
'"/>




Page: 1 2 3

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni

Post Your Comments:
(Date:11/25/2009)...,Calif.,Nov.25/PRNewswire/--Thanksgivingmealswillb...egreaterLongBeachareathankstoFaithInAction/Volunte...ome(IAH),adivisionofSCANHealthPlan.Formorethan17ye...erstodeliverwarmThanksgivingmealstoseniorsinneedin...elesandsurroundingcities. ,, "Ourwarmholidaymea...
(Date:11/25/2009)...vors of testicular cancer who were treated with ci...fects, including neurological side effects and Ray... with chemotherapy, according to a new study publi...ional Cancer Institute . , Marianne Brydy, M.D.,...ty Hospital, in Bergen, Norway, and colleagues con...
(Date:11/25/2009)...y used to fight rheumatoid arthritis, could help n..., WEDNESDAY, Nov. 25 (HealthDay News) -- A drug co...eumatoid arthritis now also shows some promise in ...tes. , The drug, rituximab (Rituxan), helped pa...ven though the disease had destroyed some of their...
(Date:11/25/2009)...ov.25/PRNewswire/-- MISSIONSkincare ®isproudt...Jude.AspartofGNC,sannualSt.Jude ThanksandGiving ca...re,s new SUPER-C(TM)LipBalm willbedonatedtoSt.Ju...kea$1,$5or$10donationatcheckoutatoneoftheir5,000+r...1millionforSt.Judeduringtheir2009 ThanksandGiving ...
(Date:11/25/2009)...avior problems that can occur in children with aut...reatment plan that includes medication combined wi...rding to Yale University researchers and their col... of the Journal of the American Academy of Child ...d by the National Institute of Mental Health (NIMH...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
... 2008 ReBuilder,Medical Technologies, Inc. (Pink ...h.D, today announced that the corporation is ready...nd transparent public equity markets., (Logo: ht... being listed only on the Pink Sheets with a large...
... Barr,Pharmaceuticals, Inc. (NYSE: BRL ) today a...all at 8:30AM Eastern time on Thursday, May 8 to d...alendar 2008, ended March 31,2008. The number to c... Eastern time on May 8 through 11:59PM Eastern tim...
...ve Rates to Enhance Flexible Premium Universal ..., April 7, 2008 In today,s uncertain,economy, man...le Life,Insurance Company announced today that it,...l Life(SM) with a built-in,Lapse Protection Rider ...
...ia is a complex type of psychotic mental illness c...eality. Huge gains in the effective treatment of i...h the development of the first generation of antip..., the negative symptoms (apathy). The second gener...
...ations that are linked to increased risk of falls ...ew of patient files in the Electronic Health Recor... drugs such as anti-anxiety medicines impact a per... and geriatricians recently reviewed the medicatio...
...t on Friends Helping Friends, FAIRFAX, Va., April...once again joining with the Food Allergy &,Anaphyl...r the eleventh,annual Food Allergy Awareness Week ...t at risk for fatal allergic reactions, and studie...
Other Medicine News:Health News:ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - 'NASDAQ, here we come!' 2Health News:Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008 2Health News:Barr Will Host An Earnings Conference Call on May 8, 2008 to Discuss the Results for the First Quarter of Calendar 2008 3Health News:AXA Equitable Helps Americans Secure Their Financial Future with More Affordable Lapse Protection Coverage 2Health News:AXA Equitable Helps Americans Secure Their Financial Future with More Affordable Lapse Protection Coverage 3Health News:AXA Equitable Helps Americans Secure Their Financial Future with More Affordable Lapse Protection Coverage 4Health News:Treatment with an anti-psychotic drug found to cause changes in metabolism earlier than expected 2Health News:Treatment with an anti-psychotic drug found to cause changes in metabolism earlier than expected 3Health News:11th Annual 'Food Allergy Awareness Week' 2
(Date:11/25/2009)..., CANOGAPARK,Calif.,Nov.25/PRNewswire/--PraxisE...ntheAmericanAcademyofFamilyPhysicians,(AAFP)Family...eyforimprovingmedicalquality,healthmaintenance,and...islation.Praxisalsoranked#1amongdoctorsindicatingt...Finally,Praxisalsorankednumberoneinthecountryinpro...
(Date:11/25/2009)..., WESTON,Fla., Nov.25/PRNewswire-FirstCall/--A...heCompany")ispleasedtoannouncethattheyhaveopenedar...nghai,China. ,, ASRhasbeenabletosecurealocation...tandproductionofcurrentandfuturehealthandsafetypro...bally.Currentlythecompanyhousesinventoryinthestate...
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--...f advanceddiagnosticandspecialtyproductstothevete...agnosticsCorporationforthesupplyofbloodgasproducts..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...passionforinnovatinginthefieldofadvancedpoint-of-c...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2American Scientific Resources Inc. Opens Shanghai Location 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3C Section Stress Could Alter Babys Immune Cells 50672 1C Section Stress Could Alter Babys Immune Cells 50672 2Prostate cancer patients disease free after five years likely to be disease free after 10 years 50669 1Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 1Pain Medicine Experts Recommend Safe and Responsible Use of Acetaminophen 50666 2
...al Dosage Form of a GLP1-analog Aimed at Impr...tes, JERUSALEM, Israel, September 16 Oramed,Phar... oral drug delivery,systems, announced today that ...a GLP1-analog., ORMD 0901 belongs to the Incretin...ncluding reduction in blood glucose levels and inh...
...nsulin,analogues, a modified form of conventional ...ong-acting analogues for controlling high blood su...betes, according to a report,funded by the Agency ....S.,Department of Health and Human Services., Con...s to be equally,effective as pre-mixed insulin ana...
Other Medicine Technology:Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 2Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels 3
Snap-In Snap-Out®-II Mini 90º Dissecting Forceps Insert
Optima III Noninsulated Strong Forceps, without ratchet
Snap-In Snap-Out®-II Python Grasping Forceps Insert
Snap-In Snap-Out®-II Strong Grasping Forceps Insert
Medicine Products: